Pharmacological agents targeting drug-tolerant persister cells in cancer
Current cancer therapy can be effective, but the development of drug resistant disease is the usual outcome. These drugs can eliminate most of the tumor burden but often fail to eliminate the rare, “Drug Tolerant Persister” (DTP) cell subpopulations in residual tumors, which can be referred to as “P...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2024-05-01
|
| Edice: | Pharmacological Research |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S1043661824001075 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|